Categories
World News

Shares rally for a second day, Dow jumps greater than 200 factors to recoup Monday’s losses

US stocks rose higher on Wednesday as stocks continued their recovery from a one-day loss earlier in the week.

Better-than-expected earnings reports from Dow members Coca-Cola and Johnson & Johnson added to the bullish mood.

The Dow Jones Industrial Average rose 286.01 points, or 0.83%, to 34,798 points. It sits less than 1% from a record. The S&P 500 was up 0.82% to 4,358.65. The Nasdaq Composite climbed 0.92% to 14,631.95.

The 30-share index rose nearly 550 points on Tuesday after falling 725 points on Monday for its worst session in eight months. The successive rallies have now completely wiped out the losses from the beginning of the week for all three indices.

“Tuesday was an oversold course in the textbook after the collapse on Monday,” Thomas Essaye of Sevens Report Research said in a report on Wednesday. “However, aside from short-term swings, we need to see returns hit rock bottom and economic growth beat estimates (two things we think will happen) for value and cyclicals to regain leadership.”

The bond market, particularly the 10-year government bond yield, is driving the equity markets. On Wednesday, the 10-year yield rose 8 basis points to 1.293% (1 basis point equals 0.01%). The yield fell to a new 5-month low on Monday before stabilizing on Tuesday. The collapse in interest rates unsettled equity investors by signaling a possible slowdown in the economy due to the spread of Covid variants or a possible error by the Federal Reserve.

Even if bonds move up, the trend is still down compared to five months ago when the 10-year price was above 1.7.

“The catalyst for why investors have become familiar with risk assets in the past two days is admittedly difficult to pin down,” said Chris Hussey of Goldman Sachs on Wednesday. “Perhaps investors have just embraced the notion that the response function to a new wave of the virus is unlikely to be the same as the response function deployed in spring 2020.”

Stocks, which would benefit most from a sustained rapid economic reopening, rose on Wednesday after recovering from Monday’s sell-off in the previous session. Carnival’s shares rose more than 9%. Las Vegas Sands was up 3%.

Energy stocks led the ongoing rally as oil continued to rebound after falling below $ 70 a barrel on Monday. The Energy Select SPDR is 3.5% higher that day.

Dow member Coca-Cola gave market sentiment an early boost after it reported quarterly sales surpassing pre-pandemic 2019 levels and raised its guidance for the full year. Coca-Cola shares gained more than 1%.

Dow member Johnson & Johnson’s stock traded almost unchanged even after the drug maker reported better-than-expected earnings and revenue for the second quarter and also raised its guidance for 2021.

Moderna has joined the S&P 500, giving the stock a 20% gain from when it was announced a week ago. The shares have gained 4.5%.

Verizon’s stocks rose slightly after reporting better-than-expected revenue and subscriber growth and raising their outlook for the full year.

Chipotle’s shares surged more than 11.5% as the Mexican fast food chain reported quarterly sales ahead of pre-pandemic levels as diners returned to their restaurants for dinner.

Netflix reported disappointing subscriber forecasts for the third quarter after the bell on Tuesday. The streaming giant expects 3.5 million net subscribers in the third quarter, nearly 2 million below analyst estimates. The company also reported results that fell short of expectations.

Netflix shares recently lost 3.2%.

According to FactSet, about 85% of the S&P 500 companies that have reported to date have beat estimates.

On Tuesday, reopening stocks rallied sharply from Monday’s sell-off sparked by a Covid-inspired global growth fear. American Airlines was up 4% and Norwegian Cruise Line was up 10%.

Some strategists see the market heading for a volatile phase in which there could be a deeper pullback. Investors juggle inflation concerns as well as new Covid cases that are recovering in the US when the delta variant spreads.

“I think what we’ve seen here are the early warning shots of a correction that we’re likely to see … in late August, September, October,” said Matt Maley, equity strategist at Miller Tabak.

However, data shows that spikes in the number of Covid cases don’t typically keep the stock market down for long. In the 14 months since the April average daily cases peak last year, case numbers in the US have risen four times while the S&P 500 remained positive.

Goldman’s Hussey said knowing better about Covid and the vaccines available to mitigate its effects could help build market confidence that U.S. economic activity is unlikely to freeze again with another wave of virus cases.

“We should expect the whiplash behavior of investors to continue”,

Rich Steinberg, chief marketing strategist at The Colony Group, told CNBC that he expects “whiplash behavior from investors to continue.”

“We will follow the rally as investors have been conditioned to buy the dip,” he said. “You’ve also been negatively conditioned to worry about the economy and the virus out of last year’s stressful world. I would describe the environment as fearful, but we’re not seeing high levels of short-termism.”

– with reports from CNBC’s Patti Domm and Michael Bloom

Categories
Politics

McCarthy threatens to drag GOP members from Home Jan. 6 committee after Pelosi rejects Trump allies Jordan and Banks

U.S. Speaker of the House Rep. Nancy Pelosi (D-CA) speaks during a weekly news conference at the U.S. Capitol July 1, 2021 in Washington, D.C.

Alex Wong | Getty Images

House Minority Leader Kevin McCarthy threatened Wednesday to withdraw all his picks for the select committee investigating the Jan. 6 Capitol invasion unless House Speaker Nancy Pelosi reinstates the two Republicans she rejected.

Less than an hour earlier, Pelosi announced that she had vetoed GOP Reps. Jim Jordan of Ohio and Jim Banks of Indiana, two of McCarthy’s five picks, from participating in the House probe of the deadly attempted insurrection by a mob of former President Donald Trump’s supporters.

Pelosi, D-Calif., said in a statement she made that decision “with respect for the integrity of the investigation” and “with an insistence on the truth and with concern about statements made and actions taken by these Members.”

On the same day of the Jan. 6 invasion, in which hundreds of Trump’s supporters broke into the Capitol to try to stop President Joe Biden’s election certification, both Jordan and Banks had voted to object to the results of the election.

CNBC Politics

Read more of CNBC’s politics coverage:

McCarthy, R-Calif., in a statement called Pelosi’s move “an egregious abuse of power” and accused her of being “more interested in playing politics than seeking the truth.”

“Unless Speaker Pelosi reverses course and seats all five Republican nominees, Republicans will not be party to their sham process and will instead pursue our own investigation of the facts,” McCarthy said.

Jordan, a staunch Trump ally and the top Republican on the House Judiciary Committee, in a brief statement said Pelosi’s actions show that her Jan. 6 probe “is nothing more than a partisan political charade.”

Banks in his own statement said Pelosi “is afraid of the facts.”

“We said all along that this was a purely partisan exercise by the Democrats and Nancy Pelosi’s rejection of me and Jim Jordan shows once again she is the most partisan figure in America today,” Banks said.

But Pelosi earlier this month had picked a Republican — Rep. Liz Cheney of Wyoming — one of her eight members on the panel. 

The Democratic-led House set up the select committee after Senate Republicans blocked a bill that would have created an independent commission to investigate the attack. Six GOP senators voted to move forward with the legislation.

Pelosi’s statement Wednesday said she told McCarthy that she would appoint the other three Republican nominees to the panel, and “requested that he recommend two other Members” to replace Jordan and Banks.

When asked at the Capitol why she rejected the two Republicans, Pelosi told NBC News, “January 6th.”

McCarthy had selected Banks to serve as the top Republican on the 13-member panel.

McCarthy’s other picks included Reps. Rodney Davis of Illinois, Kelley Armstrong of North Dakota and Texas freshman Troy Nehls. 

This is breaking news. Please check back for updates.

Categories
Health

Johnson & Johnson JNJ earnings Q2 2021

A Johnson & Johnson logo can be seen in front of a medical syringe and vial of coronavirus vaccine in this photo illustration.

Pavlo Gonchar | SOPA pictures | LightRakete | Getty Images

Johnson & Johnson said Wednesday that it expects to sell $ 2.5 billion of its Covid-19 vaccine this year, even as concerns about the effectiveness of the shot against the Delta variant mount.

When it released its financial results for the second quarter, the company also reported earnings and revenues that exceeded Wall Street’s expectations.

According to Refinitiv’s average estimates, J&J has performed as follows compared to Wall Street expectations:

  • Adjusted earnings per share: $ 2.48 per share versus an expected $ 2.27.
  • Revenue: $ 23.31 billion versus an expected $ 22.21 billion.

The company’s share price rose nearly 1% in pre-market trading, according to the report.

J & J’s pharmaceuticals business, which developed the Covid single-shot vaccine, had sales of $ 12.59 billion, up 17.2% year over year.

Jennifer Taubert, J & J’s Pharmaceuticals Chairwoman, said most of the company’s core businesses have returned to “pre-Covid levels” and the drug maker is seeing strength again in the US and Europe. The unit expects to continue seeing strong sales regardless of Covid variants or other “slip-ups” related to the pandemic, she said.

The company’s consumer division, which makes products like Neutrogena Face Wash and Listerine, had sales of $ 3.7 billion, up 13.3% from last year. The medical device business was $ 6.9 billion, an increase of 62.7%. That unit was hit hard last year when the pandemic forced hospitals to postpone elective surgeries and Americans stayed at home.

“We have all realized in the past 18 months the importance of good health and the need to choose an elective forever,” J & J’s chief financial officer Joseph Wolk told CNBC after the company released its earnings report on Wednesday .

Worldwide sales for the Covid vaccine were $ 164 million for the quarter.

The company has raised its profit and sales forecast for the year. J&J now expects full year earnings of $ 9.50 to $ 9.60 per share, compared to its previous guidance of $ 9.30 to $ 9.45 per share. The company expects revenue between $ 92.5 billion and $ 93.3 billion, compared to its previous forecast of $ 89.3 billion to $ 90.3 billion.

During a conference call, J&J executives said that given the uncertainty surrounding the need for booster vaccinations and the prevalence of highly communicable variants, it is too early to provide specific information on the outlook for the Covid vaccine for 2022 and beyond.

They said the company is expecting data from its study that will test two doses of its vaccine in the third or early fourth quarter of this year.

The financial results come a day after a new study found the J&J vaccine against the Delta and Lambda variants is much less effective than against the original virus. Researchers are now suggesting that a booster dose might be needed for J&J recipients.

The study, which has not yet been peer-reviewed, contradicts a report from the company that found the vaccine to be effective against Delta even eight months after vaccination, particularly against serious illness and hospitalization.

Delta, the dominant variant in the US, now accounts for an estimated 83% of infections in the country, according to the Centers for Disease Control and Prevention.

Wolk told CNBC on Wednesday that people should be “guarded” over the new study, adding that the results were based on blood tests in a laboratory and may not reflect the performance of the shot in a real-world setting.

“I think it’s probably best for anyone to reach out to health officials who have not yet recommended a booster, even for some shorter-duration vaccines,” he said.

Categories
Health

In an ICU, a Photographer’s View of a Determined Covid Struggle

Times Insider explains who we are and what we do, and gives a behind-the-scenes look at how our journalism comes together.

When I photographed people in Covid-19 intensive care units earlier this year, I was protected by four plastic sets: glasses, safety glasses, face shield and viewfinder. But there is no protection for the pain that you take.

I recently took pictures for a Times article about Covid treatment as a last resort called ECMO that documented coronavirus patients and the health professionals who care for them at the Providence Saint John Health Center in Santa Monica, California. The families have allowed me to share the darkest moments of their lives.

I felt privileged to be let into these sacred spaces. As a journalist, I see it as my responsibility to have the emotional bandwidth to be with people in moments that most of society cannot deal with. Despite safety guidelines that discouraged long periods of time in the intensive care unit, I would spend hours with each patient and linger for extended periods of time to get a feel for the person and bring out an emotional spectrum of moments.

The verbal interaction helps me connect with those I photograph. During this task, some people were either awake or unable to speak, and the strongest connection was often silent.

I stood next to Alfred Sablan’s bed, 25, imagining the sound of his voice and trying to feel the gentle way his mother had described. I leaned over Dr. David Gutierrez, 62, a doctor who had become a patient himself, and reminded him of who I was. He looked back, unable to answer with words, but I felt our connection through classic rock playing on his iPad.

From time to time a member of staff would come in to look for Mr. Sablan or Dr. See Gutierrez. “Are you all right?” asked a nurse when she opened the door from Dr. Gutierrez’s room opened. He nodded “yes”.

In the midst of all the pain, there were memories of grace.

Categories
Politics

CDC Says Delta Variant Makes Up an Estimated 83 % of US Circumstances

The highly infectious Delta variant now accounts for an estimated 83 percent of new coronavirus cases in the United States — a “dramatic increase” from early July, when it crossed the 50 percent threshold to become the dominant variant in this country, the director of the Centers for Disease Control and Prevention said Tuesday.

In some regions, the percentage is even higher — particularly where vaccination rates are low, Dr. Rochelle Walensky, the C.D.C. director, said during a Senate health committee hearing. Two-dose vaccines have been shown to be effective against the Delta variant but questions have been raised about Johnson & Johnson’s single-dose regimen against Delta. While almost 60 percent of U.S. adults are fully vaccinated, less than half of the total U.S. population is.

She said the C.D.C. would update its website later Tuesday to reflect the new estimate of Delta cases, which the agency derives from gene sequencing of new coronavirus cases.

The new figure comes as new cases have been rising across the United States, though cases, hospitalizations and deaths remain a fraction of their peaks. Still, public health experts are watching the increases with deep concern and Dr. Walensky warned last week that “this is becoming a pandemic of the unvaccinated.” The seven-day average now shows nearly 38,000 new daily cases, up from about 11,000 a day not long ago, according to a New York Times database.

Tuesday’s hearing was contentious at times. Senator Mitt Romney, Republican of Utah, pressed Dr. Janet Woodcock, the acting commissioner of the Food and Drug Administration, on when the F.D.A. would authorize booster shots — and was not happy when she could not provide a specific answer. Federal health officials have said booster shots are not necessary now and have pressed Pfizer for more evidence.

Other Republicans clashed with witnesses over matters including mask mandates, booster shots for Covid-19 vaccines and “gain of function” research designed to identify genetic mutations that could make a virus more powerful.

Senator Rand Paul, Republican of Kentucky, escalated his long-running attacks on Dr. Anthony S. Fauci, President Biden’s top medical adviser for the coronavirus pandemic, and accused Dr. Fauci of committing a crime by lying to Congress in May when he told senators that the National Institutes of Health did not fund “gain of function” research at a laboratory in Wuhan, China, the epicenter of the pandemic’s early days.

Dr. Fauci, in turn, accused the senator of falsely implying that the N.I.H. is somehow responsible for hundreds of thousands of deaths from the pandemic — an extraordinary exchange for the Senate, where witnesses almost always defer to lawmakers.

“I have never lied before Congress and I do not retract that statement,” Dr. Fauci declared, adding, “Senator Paul, you do not know what you are talking about, quite frankly, and I want to say that officially.”

Categories
World News

Life Expectancy in U.S. Dropped 1.5 Years in 2020, Largely From the Pandemic

The coronavirus pandemic was largely responsible for cutting American life expectancy by a year and a half in 2020, the sharpest decline in the United States since World War II, according to federal statistics released Wednesday.

An American child born today, if hypothetically all of their life in 2020 conditions, would live 77.3 years, down from 78.8 years in 2019. This is the lowest life expectancy since 2003. According to the National Center for Health Statistics, the agency that released the numbers, and part of the Centers for Disease Control and Prevention.

The troubled year also exacerbated racial and ethnic differences in life expectancy, with black and Hispanic Americans losing nearly two years more than white Americans. The life expectancy of Hispanic Americans decreased from 81.8 to 78.8, while the number of black Americans decreased from 74.7 to 71.8. The life expectancy of non-Hispanic White Americans decreased from 78.8 to 77.6.

The statistics further quantified the terrifying toll of the pandemic, which killed more than 600,000 Americans as it temporarily pushed the health system to its limits.

Life expectancy measurements are not intended to accurately predict actual life; Rather, it is a measure of the health of a population that shows either societal hardship or progress. The sheer scale of the 2020 decline has shaken researchers as it undermines decades of advances.

For the past few decades, life expectancy in the United States had risen steadily until 2014 when an opioid epidemic broke out and caused a decline rarely seen in developed countries. The decline had flattened out in 2018 and 2019.

The pandemic appears to have impacted the opioid crisis as well. According to the American Medical Association, more than 40 states have seen increases in opioid-related deaths since the pandemic began.

The sharp drop in 2020, mainly caused by Covid-19, is unlikely to be permanent. In 1918, the pandemic flu wiped Americans’ life expectancy by 11.8 years, but the number fully recovered the following year.

But even if deaths from Covid-19 decline, the economic and social effects will persist, especially among the disproportionately affected racial groups, researchers have found.

Although racial and ethnic differences in life expectancy have long existed, the differences have been narrowing for decades. In 1993, white Americans were expected to live 7.1 years longer than black Americans, but the gap was reduced to 4.1 years in 2019.

Covid-19 has undone much of that advancement: White Americans are now projected to live 5.8 years longer.

The gender gap remains: women in the United States lived to be 80.2 years old, according to the new numbers, up from 81.4 years in 2019, while men were counted at 74.5 years (after 76.3 years).

While the 1.5-year decline was mainly caused by Covid-19 and accounted for 74 percent of the negative contribution, there was also a smaller increase in accidental injuries, chronic liver disease and cirrhosis, homicides and diabetes.

As a slight silver lining, mortality rates fell from cancer, chronic lower respiratory diseases, heart disease, suicide, and certain diseases that date back to the perinatal period.

Categories
Entertainment

Is ‘Loki’ a True Marvel Variant? Or Only a Enjoyable Experiment?

One thing Marvel knows how to do is expand a story. Think back to the nascent days of the Marvel Cinematic Universe in the early ’00s. The so-called Phase 1 was about building out the superhero roster with individual film narratives that would dovetail into a big crossover movie: “The Avengers.” A decade and a half later, the crossovers are old hat, the Easter eggs are expected, and a spate of new movies and TV shows continue to provide an influx of stories and characters that branch off into their own universes.

You could even say the M.C.U. resembles a branching timeline — that’s what a member of the Time Variant Authority, or T.V.A., the bureaucracy at the center of the Disney+ series “Loki,” would say. Because for all the interdimensional fun the series has, “Loki,” which wrapped up last week, is a philosophical dialogue that also functions as a metacommentary on Marvel’s storytelling. The show’s central theme about the value of order versus chaos reflects how the M.C.U., as it expands across Disney+ and beyond, alternatively presents and breaks from contained, linear narratives and rote character types.

Although Loki (Tom Hiddleston), the sometime nemesis and sometime ally of the Avengers, was killed by Thanos in “Avengers: Infinity War,” the Asgardian now appears — resurrected! — in his own series. But it’s only a resurrection in a branding sense: The series centers on an earlier version of Loki, one who escapes the Battle of New York, from the first “Avengers” film, with the all-powerful glow-box (known as the Tesseract). His escape with the Tesseract causes a branch in the timeline, an offense that gets him first arrested by the T.V.A. and then recruited by one of the group’s agents, Mobius (Owen Wilson), to help catch a female “variant” Loki (Sophia Di Martino) who has been disregarding the rules of other timelines. In an inspired, if awkward, Freudian twist, the two Lokis fall for each other and team up to dismantle the T.V.A. before eventually finding themselves at odds.

From the beginning, “Loki” was an odd addition to the M.C.U. because it, like the recent “Black Widow” film, tried retroactively to give a back story and growth to a character who was already dead in the central M.C.U. timeline. More intriguing, it repositioned a character who had been an antagonist and a foil to Avengers like his adopted brother, the Norse golden boy Thor, as the hero of his own story, one that undermined what we had already seen happen in the franchise.

By making another version of Loki a hero, the series itself is acting as a variant. In general, Marvel has been using its latest Disney+ shows to deviate from the often wearying, even oppressive, timeline that the films have established. These side stories open up the world to more subtle, interesting narratives: “WandaVision” and “The Falcon and the Winter Soldier” allowed their heroes to develop in terms of both superhero abilities and emotional depth.

But whatever their divergences, these stories always end up leashed to the main M.C.U. narrative — Marvel’s own inviolable timeline, which often yields an awkward result. “WandaVision” used its classic TV parodies to cleverly explore the contours of grief and emotional escapism until its “Avengers” adjacency apparently demanded a requisite explosive ending. Sam Wilson (Falcon) and Bucky Barnes (the Winter Soldier) wrestled with trauma and its consequences, but the specter of Captain America, and the question of whether Sam would ultimately take up the shield, took over the story in the end.

In “Loki,” the Asgardian discovers that everything is predestined, even his identity. Loki is supposed to be a villain, and he is supposed to lose. There are no other options. What the series asks is, how does a character whose purpose is simply to accentuate, by way of contrast, the strengths and flaws of others, lead his own story?

The series certainly struggles to answer that question at first; Loki seems out of place in his own show. When the show allows him to be less of a reactionary character — he gets his own foils in the form of his many variants — he finally feels like the focus of the narrative. He evolves, proving that Loki can win and be honest and loving and compassionate. And just as “Loki” challenges how its title character is defined, so does the series break him out of the sole function he has served in the M.C.U. thus far.

As a loyal T.V.A. agent, Mobius, as he tells Loki, believes that his job is to maintain an ultimate sense of order — even if that order appears to rob the universe of free will. What happens when the timeline is all sorted out, without branches? “Just order, and we meet in peace at the end of time,” Mobius says.

“Only order? No chaos?” Loki responds. “That sounds boring.”

Marvel risks undercutting itself with “Loki” and with each bit of narrative chaos introduced by its latest shows. How can anything have emotional stakes when there is always a loophole or deus ex machina around the corner? (Indeed, “Loki” takes place in a closed loop, which by the series’s end has reset.) And at what point does narrative consistency fall apart and give us an indecipherable jumble of contradicting events?

The franchise wants to subscribe to both a traditional mode of storytelling and a bit of narrative chaos in the form of time travel, multiple universes and nonlinear shifts in time and space — all of which allow for deviations from the main story line. But the more variant stories we get, the more unstable and convoluted the whole structure becomes.

“Loki” is a fun touch of chaos for Loki fans, myself included, but it makes me wonder how much longer the relative order of the M.C.U. franchise’s central chronology can sustain the backpedaling and jumps and reversals, even within their own pockets of time. The vast megaverse that is Marvel already hosts countless characters and stories, and yet having one in which Loki is still alive is infinitely more fun.

But as delightful as “Loki” is conceptually, to me it felt like simply a fun, diverting experiment. What Marvel will do with the results of this experiment is another story. This season’s cliffhanger ending means that the full measure of the series’s success and impact is still to come, whether in the second season promised in the finale or in the broader M.C.U.

Is “Loki” truly a variant within the M.C.U.? Will it introduce reverberations throughout the films and TV shows going forward, or will it be essentially isolated in its own playful thought bubble? If the former, I suspect the Marvel won’t be able to sustain the full heft of the master narrative, with all of those branches, forever — that is, unless Marvel fully embraces chaos and lets the M.C.U. fracture into separate multiverses without such a restrictive overarching timeline. After all, if the god of mischief has taught us anything, it’s that a little bit of chaos can go a long way.

Categories
Health

U.S. life expectancy dropped by 1.5 years in 2020, greatest drop since WWII

A woman looks at the “Naming the Lost Memorials,” as US deaths from coronavirus disease (COVID-19) are expected to exceed 600,000, in Green Wood Cemetery in Brooklyn, New York, the United States, June 10, 2021 .

Brendan McDermid | Reuters

The Covid-19 pandemic cut average life expectancy in the United States by about a year and a half last year, which is the largest decline in a year since World War II, according to new data from the Centers for Disease Control and Prevention.

According to the report released Wednesday by the CDC’s National Center for Health Statistics, Americans are now expected to live an average of 77.3 years, compared with 78.8 years in 2019. Hispanics saw the sharpest decline in life expectancy last year, followed by black Americans.

“The decline in life expectancy between 2019 and 2020 is primarily due to deaths from the pandemic,” the report said. Covid deaths accounted for nearly 75% of the decline. More than 609,000 Americans have died in the pandemic to date, with around 375,000 of those people dying last year, according to the CDC.

About 11% of the decrease is due to an increase in deaths from accidents or accidental injuries. Drug overdose deaths, which increased by 30% during the pandemic, accounted for about a third of accidental injuries last year.

The life expectancy of American men decreased 1.8 years from 2019 to 2020, while the life expectancy of American women decreased 1.2 years from 2019.

“The difference in life expectancy between the sexes was 5.7 years in 2020, increasing from 5.1 in 2019,
read the report.

Hispanic Americans typically have longer life expectancies than non-Hispanic blacks or whites, but according to the report, Hispanic life expectancy declined more than any other ethnic group in the past year. The life expectancy of all Hispanics decreased by three years, from 81.8 years in 2019 to 78.8 years in 2020. Hispanic men suffered a decrease of 3.7 years in 2020.

“Covid-19 was responsible for 90% of the decline in life expectancy in the Hispanic population,” the report said.

The reduction in the life expectancy gap between white and Hispanic populations “is a clear indicator of the deterioration in the health and mortality results of a population that, paradoxically, before the Covid-19 pandemic was able to defy the expectations of its disadvantaged socio-economic profile “says the report.

Black Americans experienced the second largest decline in life expectancy, falling nearly 3 years from 74.7 years in 2019 to 71.8 years in 2020, its lowest level since 2000, the report said. Covid-19 was responsible for 59% of the decline in life expectancy among blacks.

Among white Americans, life expectancy fell 1.2 years in 2020, from 78.8 years in 2020 to 77.6 years, its lowest level since 2002. Covid-19 accounted for 68% of the decline in life expectancy among whites last year responsible.

Covid-19 was the third leading cause of death last year, and “the overall death rate was highest among non-Hispanic blacks and non-Hispanic Native American or Alaskan people,” the CDC said in its preliminary mortality report in April.

The life expectancy of black Americans has consistently lagged whites, but the last time the life expectancy gap between blacks and whites was this large was in 1999, according to the report.

Other factors that contributed to the decline in life expectancy in 2020 are homicides, which accounted for 3% of the decline, and diabetes and chronic liver disease, which accounted for 2.5% and 2.3%, respectively.

Categories
Health

Dr. Paul Auerbach, Father of Wilderness Drugs, Dies at 70

Dr. Auerbach said it was imperative never to get too comfortable when dealing with the whims of nature. “You have to be afraid when you go into work,” he said. “You have to stay humble.”

Paul Stuart Auerbach was born on Jan. 4, 1951, in Plainfield, N.J. His father, Victor, was a patents manager for Union Carbide. His mother, Leona (Fishkin) Auerbach, was a teacher. Paul was on his high school wrestling team and grew up spending summers on the Jersey Shore.

He graduated from Duke in 1973 with a bachelor’s degree in religion and then enrolled in Duke’s medical school. He met Sherry Steindorf at U.C.L.A., and they were married in 1982. (In the 1980s he worked part-time as a sportswear model.) Dr. Auerbach studied at Stanford’s business school shortly before joining the university’s medical faculty in 1991.

In addition to his wife, he is survived by two sons, Brian and Daniel; a daughter, Lauren Auerbach Dixon; his mother; a brother, Burt; and a sister, Jan Sherman.

As he grew older, Dr. Auerbach became increasingly devoted to expanding the field of wilderness medicine to account for the uncertainties of a new world. In revising his textbook, he added sections about handling environmental disasters, and, with Jay Lemery, he wrote “Enviromedics: The Impact of Climate Change on Human Health,” published in 2017.

Last year, shortly before he received his cancer diagnosis, the coronavirus pandemic began to take hold, and Dr. Auerbach decided to act.

“The minute it all first happened, he started working on disaster response,” his wife said. “Hospitals were running out of PPE. He was calling this person and that person to learn as much as he could. He wanted to find out how to design better masks and better ventilators. He never stopped.”

Categories
Politics

Trump pal Tom Barrack’s arrest places the highlight on United Arab Emirates

The arrest on Tuesday of a key Trump ally accused of illegally lobbying the United Arab Emirates shows just how much the oil-rich Middle Eastern country ingratiated itself with the United States during the Trump administration.

Between arms deals and diplomatic deals, the UAE, a relatively small spit of land between Saudi Arabia and the Persian Gulf, played an important role in former President Donald Trump’s policies in the region.

An indictment filed in New York federal court on Tuesday alleges that Tom Barrack, a longtime friend and business associate of Trump, worked for years to develop that relationship by secretly advancing the interests of the UAE through his influence on Trump’s 2016 presidential campaign and administration promoted.

Barrack, a 74-year-old private equity billionaire who was president of Trump’s founding fund in 2017, was arrested Tuesday morning in Los Angeles.

The seven-point indictment also accuses Barrack of obstructing the judiciary and making several false statements in an interview with federal authorities in 2019. The indictment also includes Matthew Grimes, 27, of Aspen, Colorado; and a 43 year old UAE citizen, Rashid Sultan Rashid Al Malik Alshahhi.

A judge ordered the arrest of Barrack and Grimes, with the bail hearing scheduled for Monday.

CNBC policy

Read more about CNBC’s political coverage:

“Mr. Barrack volunteered to help investigators from the start. He is not guilty and will plead not guilty,” a Barrack spokesman told CNBC in a statement.

The indictment states that Barrack advised American officials informally on Middle East policy and sought a leadership role in the US government, including serving as special envoy for the Middle East.

A Trump spokeswoman did not respond to CNBC’s request to comment on Barrack’s arrest.

The United Arab Emirates – an amalgamation of seven Arab monarchies with just under 10 million inhabitants – are home to several sovereign wealth funds such as the Abu Dhabi Investment Authority, which has a weight of almost 700 billion US dollars. According to the fund’s website, between 35% and 50% of the ADIA’s investments are parked in North America.

Barrack is not the first person in Trump’s circle whose ties to the United Arab Emirates have been put to the test.

While serving as an advisor to the United Arab Emirates, George Nader, who later pleaded guilty to indicting child sex and porn in a case that emerged from Special Counsel Robert Mueller’s Russia investigation, had $ 2.5 million Transferred to the Trump fundraiser Elliott Broidy, the Associated Press reported in 2018.

Nader paid the money to Broidy, sources told the AP, to fund efforts to convince Washington to harden its stance on Qatar, a U.S. ally but a bitter rival of the UAE.

The New York Times also reported in 2018, citing hundreds of pages of correspondence between the two men, a campaign by Saudi Arabia and the United Arab Emirates to influence Trump’s White House.

Broidy pleaded guilty to a conspiracy to act as an unregistered foreign agent in October 2020.

A U.S. Air Force F-35 Lightning II Joint Strike Fighter approaches Eglin Air Force Base, Florida.

U.S. Air Force photo by Samuel King Jr.

A dealmaker

The United Arab Emirates, in which Trump established business relationships before taking office, established itself as an important partner of the United States in the region during the Trump administration.

The UAE signed the 2020 Abraham Agreement, which took steps to normalize diplomatic relations between Arab nations and Israel. The pact made the United Arab Emirates the first state on the Persian Gulf to normalize relations with Israel and the third Arab country after Egypt and Jordan.

Last November, then Secretary of State Mike Pompeo announced that the Trump administration would sell more than $ 23 billion worth of military equipment to the UAE “in recognition of our deepening relationship” and “in recognition of the nation’s need for advanced equipment Defense skills to deter and defend against ”. increased threats from Iran. “

In April, President Joe Biden’s administration reportedly notified Congress that it would continue selling weapons from the Trump era. The deal includes dozens of Lockheed Martin’s F-35 fighter jets, America’s most expensive weapons platform, as well as General Atomics-armed MQ-9 Reaper drones.

The United States, the world’s largest arms exporter, sends half of its arms to the Middle East, according to a report by the Stockholm International Peace Research Institute. Arms imports to the Middle East were 25% higher from 2016 to 2020 than from 2011 to 2015.

After Saudi Arabia and Qatar, the United Arab Emirates is the second largest buyer of US arms in the Middle East.

– Amanda Macias reported from Washington. Kevin Breuninger reported from New York.